Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing

Eugene Varfolomeev1, Heather Maecker, Darcie Sharp

  • 1Department of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080, USA.

Insights

Apo2 ligand/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) activates kinase pathways via a secondary signaling complex, distinct from its cell death pathway. This mechanism enhances immune responses and potentially aids in clearing apoptotic cells.

Area of Science:

  • Cellular signaling pathways
  • Immunology
  • Apoptosis research

Background:

  • Apo2 ligand/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) primarily induces apoptosis via caspases.
  • Tumor necrosis factor (TNF) activates gene transcription through inhibitor of kappaB kinase (IKK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) pathways.
  • The mechanisms by which Apo2L/TRAIL stimulates these kinases and its relation to apoptosis remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Apo2L/TRAIL-mediated kinase pathway activation.
  • To investigate the role of secondary signaling complexes in Apo2L/TRAIL signaling.
  • To understand the functional consequences of Apo2L/TRAIL-induced kinase activation.

Main Methods:

  • Analysis of primary and secondary signaling complex formation after Apo2L/TRAIL stimulation.
  • Investigating the requirement of specific proteins (FADD, caspase-8, RIP1, TRAF2, NEMO) for kinase activation.
  • Measuring the secretion of chemokines (interleukin-8, monocyte chemoattractant protein-1) and assessing macrophage migration.

Main Results:

  • Apo2L/TRAIL induces a secondary signaling complex containing FADD, caspase-8, RIP1, TRAF2, and NEMO/IKKgamma, following primary death-inducing signaling complex (DISC) assembly.
  • Secondary complex formation and subsequent activation of JNK, p38, and IKK pathways are dependent on specific components like FADD, caspase-8, RIP1, TRAF2, and NEMO.
  • Apo2L/TRAIL stimulation led to the secretion of IL-8 and MCP-1, enhancing macrophage migration.

Conclusions:

  • Apo2L/TRAIL utilizes a distinct secondary signaling complex to activate kinase pathways, sharing components with TNF signaling.
  • This kinase activation by Apo2L/TRAIL contributes to immune cell recruitment.
  • Kinase activation by Apo2L/TRAIL may facilitate the clearance of apoptotic cells through enhanced phagocytosis.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...